PET Study Clinical Trials

• A Positron Emission Tomography (PET) Study to Assess the Degree of Dopamine-2 (D2) Receptor Occupancy in the Human Brain After Single Doses of BL-1020 or Perphenazine in Healthy Male Subjects Using [11C]Raclopride as PET Tracer
  ClinicalTrials.gov Identifier: NCT00480246 - Recruiting
  Healthy
  
• Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00358098 - Recruiting
  Metastatic Breast Cancer
  
• A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients with Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00123747 - Recruiting
  Lung Neoplasms
  
• Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00135161 - Active, not recruiting
  neoplasms (squamous cell carcinoma of the head and neck region)
  
• PET Imaging in Post Radiation Evaluation of Head and Neck Tumours "PET PREVENT"
  ClinicalTrials.gov Identifier: NCT00147472 - Recruiting
  Cancer of the Head and Neck
  
• Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
  ClinicalTrials.gov Identifier: NCT00373711 - Recruiting
  Thyroid Cancer
  
• PET Imaging of Brain mGluR5 Receptors Using [18F]SP203
  ClinicalTrials.gov Identifier: NCT00538798 - Recruiting
  Glutamate Receptor; mGlur5 Protein; Excitatory Amino Acid Receptors; Drug Kinetics; PET Scan
  
• PET Imaging in Potentially Surgically Resectable Non-Small Cell Lung Cancers (ELPET Trial)
  ClinicalTrials.gov Identifier: NCT00136890 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma
  
• PET Imaging in Stage III Non-Small Cell Lung Cancer (PET START Trial)
  ClinicalTrials.gov Identifier: NCT00136864 - Recruiting
  Non-Small-Cell Lung Carcinoma
  
• Quantification of pulmonary neutrophil activity in cystic fibrosis using radiolabeled fluorodeoxyglucose and PET imaging
  ClinicalTrials.gov Identifier: NCT00023465 - Recruiting
  Cystic Fibrosis
  
• PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
  ClinicalTrials.gov Identifier: NCT00343707 - Active, not recruiting
  Social Anxiety Disorder
  
• Remission Evaluation Before Intensified Treatment in Lymphoma: Impact of Positron Emission Tomography (PET) Using Fluorine-18-Floro-Deoxyglucose (FDG) in the Therapeutic Prescription. Medico-Economic Randomised Study
  ClinicalTrials.gov Identifier: NCT00169598 - Active, not recruiting
  Lymphoma
  
• Validation of 18F-MISO-PET and 18F-FLT-PET
  ClinicalTrials.gov Identifier: NCT00159978 - Recruiting
  Head and Neck Neoplasms
  
• The Impact of Renin-Angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study
  ClinicalTrials.gov Identifier: NCT00264641 - Active, not recruiting
  Hypoglycemia; Cognitive Impairment
  
• Excitatory Amino Acids and Activated Microglia After Traumatic Brain Injury: a (R)-[11C]PK11195 PET Study
  ClinicalTrials.gov Identifier: NCT00205582 - Active, not recruiting
  Traumatic Brain Injury
  
• Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.
  ClinicalTrials.gov Identifier: NCT00468806 - Recruiting
  Healthy
  
• Cardiac Water and Fluoromethane PET
  ClinicalTrials.gov Identifier: NCT00205127 - Active, not recruiting
  Healthy Volunteers
  
• A Study To Investigate The Ability To Use 18FDG PET Scanning To Monitor The Effectiveness Of New Drugs In COPD Patients.
  ClinicalTrials.gov Identifier: NCT00472264 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Positron Emission Tomography (PET) to Study Brain Signaling
  ClinicalTrials.gov Identifier: NCT00044200 - Recruiting
  Healthy
  
• Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers
  ClinicalTrials.gov Identifier: NCT00531193 - Recruiting
  Healthy
  
• Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
  ClinicalTrials.gov Identifier: NCT00435695 - Recruiting
  Healthy
  
• Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
  ClinicalTrials.gov Identifier: NCT00163176 - Recruiting
  Head and Neck Neoplasms
  
• Para-Aortic Lymph Nodal Staging and Evaluation of Treatment Outcome by 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Advanced Cancer Cervix
  ClinicalTrials.gov Identifier: NCT00193752 - Recruiting
  Cancer of Cervix; Cervical Cancer; Cancer of the Cervix; Cervix Cancer
  
• PET Imaging of Regional Variation in Insulin Sensitivity of Adipose Tissue in Humans
  ClinicalTrials.gov Identifier: NCT00222768 - Active, not recruiting
  Diabetes; Obesity
  
• PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors
  ClinicalTrials.gov Identifier: NCT00269373 - Recruiting
  Unknown Primary Tumor
  
• PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
  ClinicalTrials.gov Identifier: NCT00201942 - Completed
  Breast Cancer
  
• Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study
  ClinicalTrials.gov Identifier: NCT00228514 - Completed
  Rosuvastatin; Heart Failure; Positron Emission Tomography (PET)
  
• A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
  ClinicalTrials.gov Identifier: NCT00453362 - Recruiting
  Lung Cancer
  
• Safety and Efficacy Study of FLT Radiolabeled Imaging Agent With PET Scan in Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00572728 - Recruiting
  Breast Cancer
  
• Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00576563 - Recruiting
  Rectum Cancer
  
• Exploratory Study Evaluation FDG-PET as a Predictive Marker for Therapy With RAD 001 in Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00529802 - Recruiting
  Carcinoma, Renal Cell
  
• The Role of FLT-PET in Proliferation of Colorectal Livermetastases
  ClinicalTrials.gov Identifier: NCT00145665 - Recruiting
  Colorectal Neoplasms; Liver Neoplasms; Recurrence
  
• The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma
  ClinicalTrials.gov Identifier: NCT00498667 - Active, not recruiting
  Agressive B Cells Lymphoma
  
• Study of PET Scans and Serotonin in Hot Flashes Treatment
  ClinicalTrials.gov Identifier: NCT00249847 - Recruiting
  Hot Flashes
  
• A Proof-of-Concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
  ClinicalTrials.gov Identifier: NCT00565721 - Recruiting
  High-Grade Glioma; Lung Cancer; Head & Neck Cancer; Sarcoma; Melanoma
  
• PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
  ClinicalTrials.gov Identifier: NCT00019565 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• PET Study in Panic Disorder According to Paroxetine Treatment
  ClinicalTrials.gov Identifier: NCT00515749 - Recruiting
  Panic Disorder
  
• Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT
  ClinicalTrials.gov Identifier: NCT00534989 - Active, not recruiting
  Lymphoma, Non-Hodgkin; Hodgkin Disease
  
• PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00236275 - Active, not recruiting
  Advanced Breast Cancer
  
• PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
  ClinicalTrials.gov Identifier: NCT00562198 - Not yet recruiting
  Parkinson´s Disease
  
• Correlation of PET-CT Studies With Serum Protein Analysis
  ClinicalTrials.gov Identifier: NCT00547742 - Recruiting
  Cancer
  
• Usefulness of FDG-PET for Advanced Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00146458 - Active, not recruiting
  Cervical Cancer
  
• Image Fusion PET, CT and 3D-Ultrasound Examinations
  ClinicalTrials.gov Identifier: NCT00302094 - Recruiting
  Anal Cancer
  
• ADNI: Alzheimer's Disease Neuroimaging Initiative
  ClinicalTrials.gov Identifier: NCT00106899 - Active, not recruiting
  Alzheimer's Disease
  
• Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning
  ClinicalTrials.gov Identifier: NCT00184782 - Recruiting
  Colorectal Neoplasms
  
• The Utility of FDG-PET for Radiation Treatment in NSCLC
  ClinicalTrials.gov Identifier: NCT00385164 - Recruiting
  Lung Neoplasms; Positron Emission Tomography
  
• PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28
  ClinicalTrials.gov Identifier: NCT00407693 - Recruiting
  Healthy Subjects
  
• F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
  ClinicalTrials.gov Identifier: NCT00180193 - Recruiting
  Brain Tumor
  
• Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients
  ClinicalTrials.gov Identifier: NCT00304694 - Recruiting
  Nasopharyngeal Cancer
  
• Dynamic PET Acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment
  ClinicalTrials.gov Identifier: NCT00294840 - Recruiting
  Pancreatic Cancer
  
• PET Changes in Alzheimer's Disease (AD)
  ClinicalTrials.gov Identifier: NCT00094913 - Active, not recruiting
  Alzheimer Disease
  
• Quantitation of Left Ventricular Ejection Fraction as Part of F-18 FDG Whole Body PET Scans For Tumor Staging
  ClinicalTrials.gov Identifier: NCT00499382 - Recruiting
  Advanced Cancers
  
• PET/CT to Identify "Vulnerable" Arterial Plaque
  ClinicalTrials.gov Identifier: NCT00416065 - Recruiting
  Cancer
  
• PET Imaging of DHA Metabolism
  ClinicalTrials.gov Identifier: NCT00074503 - Recruiting
  Healthy
  
• Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
  ClinicalTrials.gov Identifier: NCT00188149 - Recruiting
  Hodgkin Disease
  
• Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00188929 - Recruiting
  Lymphoma, Non-Hodgkin
  
• Using PET-CT to Target and Validate Low-Frequency TMS as Treatment for Tinnitus
  ClinicalTrials.gov Identifier: NCT00329524 - Recruiting
  Tinnitus
  
• Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules
  ClinicalTrials.gov Identifier: NCT00537797 - Recruiting
  Thyroid Neoplasms
  
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00547976 - Recruiting
  Atherosclerosis; Healthy
  
• Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans
  ClinicalTrials.gov Identifier: NCT00253279 - Recruiting
  Burn
  
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [11C]PBR28
  ClinicalTrials.gov Identifier: NCT00526916 - Recruiting
  Neurocysticercosis; Epilepsy
  
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [18F]FBR
  ClinicalTrials.gov Identifier: NCT00527579 - Recruiting
  Neurocysticercosis; Epilepsy
  
• Effects of Pet Therapy on Pain in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00103688 - Recruiting
  
  
• Pre-Treatment Positron Emission Topography (PET) Scanning for Increasing Success in Antidepressant Treatment
  ClinicalTrials.gov Identifier: NCT00456014 - Recruiting
  Depression
  
• PET Scanning and [11C]MeS-IMPY to Measure Amyloid in Brain
  ClinicalTrials.gov Identifier: NCT00407576 - Recruiting
  Alzheimer's Disease; Neurodegenerative Disease; Dementia
  
• PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
  ClinicalTrials.gov Identifier: NCT00544219 - Recruiting
  Lymphoma
  
• Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00139191 - Completed
  Prostate Cancer
  
• PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases
  ClinicalTrials.gov Identifier: NCT00382252 - Recruiting
  Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
  ClinicalTrials.gov Identifier: NCT00550628 - Recruiting
  Colorectal Cancer; Neoplasm of Uncertain Malignant Potential
  
• Evaluating the Remote Effects of Stroke with MRI and PET Scans
  ClinicalTrials.gov Identifier: NCT00063180 - Recruiting
  Cerebrovascular Accident
  
• Positron Emission Tomography (PET) Interest in the Follow Up of Colorectal Cancer Stage II and III
  ClinicalTrials.gov Identifier: NCT00199654 - Recruiting
  Colorectal Cancer
  
• Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
  ClinicalTrials.gov Identifier: NCT00180154 - Recruiting
  Lung Cancer
  
• PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00362973 - Recruiting
  Breast Cancer
  
• 18F-NaF PET in Detecting Metastatic Bone Lesion for Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00414934 - Recruiting
  Non-Small-Cell Lung Cancer
  
• PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary Malignancy
  ClinicalTrials.gov Identifier: NCT00530283 - Recruiting
  Squamous Cell Cancer
  
• The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
  ClinicalTrials.gov Identifier: NCT00230269 - Recruiting
  Head and Neck Cancer
  
• Use of PET/CT to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00254683 - Recruiting
  Rectal Cancer
  
• Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
  ClinicalTrials.gov Identifier: NCT00302146 - Recruiting
  Glucocerebrosidase Mutations; Gaucher Disease
  
• Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan
  ClinicalTrials.gov Identifier: NCT00351650 - Recruiting
  Type I Diabetes
  
• 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF)
  ClinicalTrials.gov Identifier: NCT00363402 - Recruiting
  Cystic Fibrosis
  
• Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients
  ClinicalTrials.gov Identifier: NCT00468078 - Recruiting
  Parkinson's Disease
  
• PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00346125 - Recruiting
  Sarcoma
  
• Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00199680 - Recruiting
  Cervical Cancer
  
• Fast-Track Diagnosis for Lung Cancer Suspects With PET-CT and EUS
  ClinicalTrials.gov Identifier: NCT00556647 - Recruiting
  Lung Cancer
  
• Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
  ClinicalTrials.gov Identifier: NCT00522639 - Recruiting
  Lung Cancer; SCLC; NSCLC
  
• Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00181168 - Recruiting
  Thyroid Cancer
  
• PET/CT to Image Hypoxia in Head and Neck Tumours
  ClinicalTrials.gov Identifier: NCT00395109 - Recruiting
  Head and Neck Cancer.
  
• FDG-PET Imaging in Painful Joint Prosthesis
  ClinicalTrials.gov Identifier: NCT00194285 - Recruiting
  Painful Joint Prostheses
  
• FDG-PET Imaging in Complicated Diabetic Foot
  ClinicalTrials.gov Identifier: NCT00194298 - Recruiting
  Diabetic Foot Disease
  
• PET Scan in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002981 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• The Use of Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) to Assess the Effects of Anti-Neoplastic Therapy on Tumor Associated Vasculature
  ClinicalTrials.gov Identifier: NCT00001709 - Recruiting
  Neoplasm
  
• PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00004152 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity
  ClinicalTrials.gov Identifier: NCT00067821 - Recruiting
  Brain Neoplasms
  
• PET Scanning in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00024622 - Recruiting
  Parkinson Disease
  
• FDG PET-CT in Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00282906 - Recruiting
  Prostate Cancer
  
• Use of FDG PET/CT to Evaluate Crohn Disease
  ClinicalTrials.gov Identifier: NCT00383344 - Recruiting
  Crohn Disease
  
• FACBC PET/CT for Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00562315 - Recruiting
  Prostate Cancer
  
• Phase I Trial From GRID 18F-FDG-PET Biological Imaging-Guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area
  ClinicalTrials.gov Identifier: NCT00528294 - Recruiting
  Head and Neck Tumors
  
• Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET
  ClinicalTrials.gov Identifier: NCT00180245 - Recruiting
  Head and Neck Cancer
  
• PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00335751 - Recruiting
  Sarcoma